Allergen, Tree, Pine/Australian Tree
Also known as: PINEAUS
Use
This test is used for the quantitative measurement of allergen-specific Immunoglobulin E (IgE) to Pine/Australian Tree allergens. The detected IgE levels help in identifying allergic sensitization to these specific tree allergens and can be instrumental in diagnosing and managing allergic conditions like allergic rhinitis and asthma associated with pine tree pollen exposure. However, the concentration of IgE may not correlate with the degree of clinical response or skin test results, as other factors may contribute to allergic reactions. Correlation with clinical history and other tests is essential for accurate diagnosis.
Special Instructions
Not provided.
Limitations
The concentration of allergen-specific IgE detected does not necessarily correlate with the severity of clinical symptoms or the results of skin tests when challenged with the allergen. A negative result does not exclude the possibility of an allergy or even an anaphylactic reaction upon exposure to the allergen. Clinical correlation and further testing may be necessary for a comprehensive diagnosis.
FDA ApprovedNew York Approved
Methodology
Immunoassay (Fluorescent Enzyme Immunoassay)
Biomarkers
Tree, Pine/Australian
Protein
LOINC Codes
- 6032-7 - Australian pine IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect in a serum separator tube. Separate serum from cells ASAP or within 2 hours of collection.
Patient Preparation
Multiple patient encounters should be avoided.
Storage Instructions
Refrigerated
Causes for Rejection
Hemolyzed, icteric, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant